400
Participants
Start Date
November 30, 2025
Primary Completion Date
August 31, 2031
Study Completion Date
August 31, 2031
Bedaquiline
Frequency: daily Route of administration: oral
Linezolid
Frequency: daily Route of administration: oral
Pretomanid
Frequency: daily Route of administration: oral
Moxifloxacin
Frequency: daily Route of administration: oral
Control Arm FQ-S MDR/RR-TB regimen, designed according to latest international guidelines
The local SOC regimen consistent with preferred regimen(s) in international guidelines. In most cases this will be 24 weeks of bedaquiline, pretomanid, linezolid, and moxifloxacin (6BPaLM). Doses and durations of each component may change based on the latest international guidelines and the local SOC.
RECRUITING
National Center for Communicable Diseases, Ulaanbaatar
NOT_YET_RECRUITING
Institute of Chest Diseases, Kotri
NOT_YET_RECRUITING
Hospital Nacional Sergio E. Bernales, Lima
NOT_YET_RECRUITING
Policlínico SES, Lima
NOT_YET_RECRUITING
Mulago National Referral Hospital, Kampala
NOT_YET_RECRUITING
Hanoi Lung Hospital, Hanoi
Johns Hopkins University
OTHER
University of California, San Francisco
OTHER